Matinas BioPharma Holdings (MTNB) Non-Current Deferred Tax Liability (2015 - 2026)
Matinas BioPharma Holdings (MTNB) posted Non-Current Deferred Tax Liability of $257,000 for Q2 2026, unchanged from $257,000 a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Matinas BioPharma Holdings (MTNB) Non-Current Deferred Tax Liability (2015 - 2026) Analysis & Trends
Since Q3 2015, Matinas BioPharma Holdings has reported Non-Current Deferred Tax Liability for 44 quarters.
- Annual Non-Current Deferred Tax Liability shows a five-year compound annual growth rate of -5.5% (FY2020 to FY2025).
- In prior years, Matinas BioPharma Holdings' Non-Current Deferred Tax Liability was $257,000 in FY2024 (-24.6%), $341,000 in FY2023 (unchanged), $341,000 in FY2022 (unchanged) and $341,000 in FY2021 (-0.1%).
- Quarterly Non-Current Deferred Tax Liability has run from a low of $257,000 in Q4 2024 to a high of $341,265 in Q3 2022 over five years.
- Across the past five years, year-over-year decline in Non-Current Deferred Tax Liability ran from 0.0% in Q2 2026 to 24.6% in Q4 2024.
- According to Business Quant data, Non-Current Deferred Tax Liability for the three prior quarters was $257,000 (Q1 2026), $257,000 (Q4 2025) and $257,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Matinas BioPharma Holdings | 16.34 Mn | 3.74 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 257,000.00 |
| Mar 31, 2026 | 257,000.00 |
| Dec 31, 2025 | 257,000.00 |
| Sep 30, 2025 | 257,000.00 |
| Jun 30, 2025 | 257,000.00 |
| Mar 31, 2025 | 257,000.00 |
| Dec 31, 2024 | 257,000.00 |
| Sep 30, 2024 | 341,000.00 |
| Jun 30, 2024 | 341,000.00 |
| Mar 31, 2024 | 341,000.00 |
| Dec 31, 2023 | 341,000.00 |
| Sep 30, 2023 | 341,000.00 |
| Jun 30, 2023 | 341,000.00 |
| Mar 31, 2023 | 341,000.00 |
| Dec 31, 2022 | 341,000.00 |
| Sep 30, 2022 | 341,265.00 |
| Jun 30, 2022 | 341,265.00 |
| Mar 31, 2022 | 341,265.00 |
| Dec 31, 2021 | 341,000.00 |
| Sep 30, 2021 | 341,265.00 |
API Access
Matinas BioPharma Holdings Non-Current Deferred Tax Liability API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deferred-tax-liability&ticker=MTNB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deferred-tax-liability", "ticker": "MTNB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deferred-tax-liability&ticker=MTNB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();